Busca
Resultados da Busca
Select an image to start the slideshow
Plasminogen Activator Inhibitor – 1’s Effects on Blood-Brain Barrier Permeability
1 of 47
Hijacking the Plasminogen Activator System for Possible Therapeutic Potential for Neurovascular and Neurodegenerative Diseases
2 of 47
Abnormal dopamine signaling in a mouse model of dystonia
3 of 47
Neurochemical, neuroprotective, and behavioral effects of enhanced
vesicular storage of dopamine
4 of 47
A role for the synaptic vesicle glycoprotein 2C (SV2C) in
dopamine homeostasis and Parkinson's disease
5 of 47
Differential expression of vesicular glutamate transporter 2 in
thalamostriatal terminals
6 of 47
Functional and structural subdomains of the intracellular loop
domain of the GABAAR α1 subunit
7 of 47
Neuroanatomical Substrates for Head Movements in Humans
8 of 47
Neuropathology of Striatal Interneurons in Transgenic Nonhuman
Primate Models of Huntington's Disease
9 of 47
Analysis of Dysbindin-BLOC-1 Complex Mechanisms in the
Neuromuscular Synapse of the Fruit Fly Drosophila melanogaster
10 of 47
D1 and D5 dopamine receptor signaling inarea 9 of the Macaca mulatta dorsolateral prefrontalcortex
11 of 47
Changes in VGLUT1 Synaptic Connectivity and Presynaptic Inhibition Following Nerve Crush
12 of 47
Neuropharmacology of 3,4-methylenedioxymethamphetamine (MDMA,
"ecstasy") and its stereoisomers
13 of 47
A new mouse model of L-DOPA-responsive dystonia
14 of 47
Investigating the expression profile of the Scn8a
voltage-gated sodium channel in the cerebral cortex and the
thalamus
15 of 47
Role of Glutamate on Dopamine Neurochemistry and the Behavioral
Pharmacology of Cocaine in Squirrel Monkeys
16 of 47
Metabotropic glutamate and adenosine receptors in the monkey
striatopallidal complex and their involvement in Parkinsonism:
Anatomy, physiology, and behavior
17 of 47
Effects of Dopamine D1-Like Receptor Activation in the Internal Pallidal Segment and the Substantia Nigra Pars Reticulata of Normal and Parkinsonian Primates
18 of 47
Oxytocin and affiliative behavior in prairie voles
19 of 47
Serotonin 5-HT2C Receptor-Mediated Modulation of the Behavioral
and Neurochemical Effects of Cocaine in the Squirrel Monkey
20 of 47
Oxytocin modulates distributed immediate early gene expression across forebrain nuclei in male prairie voles
21 of 47
Cell Type-Dependent Activities of the Ubiquitin-Proteasome Systemand Selective Neurodegeneration
22 of 47
Ferritin as a Transgenic MRI Reporter in Mouse Embryonic Stem Cells
23 of 47
Microglial motility under pro-inflammatory conditions in situ:
Relevance to neurodegeneration
24 of 47
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
25 of 47
Effects of pharmacological dopamine β-hydroxylase
inhibition on cocaine-induced behavior and neurochemistry
26 of 47
Moduation of post-synaptic ion channels by CaMKII
27 of 47
Intrinsic and Synaptic Determinants of Spike Timing Revealed by
Phase Response Analyses of a Morphological Globus Pallidus Neuron
Model
28 of 47
Cholinergic Interneurons: Distribution and Synaptic Inputs in the
Primate Putamen
29 of 47
Glutamatergic Inputs to the Monkey Subthalamic Nucleus: A
Comparison of Relative Abundance, Synaptology and Functional
Connectivity in Normal versus Parkinsonian Conditions.
30 of 47
Molecular Pathogenesis of DYT1 Dystonia
31 of 47
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
32 of 47
Regulation of Drosophila Synaptic Function and Plasticity by a
Schizophrenia Susceptibility Network.
33 of 47
Effects of 5-HT2A Receptor Antagonism on Cocaine
Self-administration, Cocaine-induced Reinstatement, and
Cocaine-induced Dopamine Overflow in Rhesus Monkeys
34 of 47
Effects of stress on A-type K+ channel subunit Kv4.2 distribution
in the basolateral amygdala
35 of 47
Molecular Targets of HBCDD in the Hippocampus
36 of 47
Subcellular & Subsynaptic Localization of Group IMetabotropic Glutamate Receptors in the Nucleus Accumbens
37 of 47
Ubiquitin C-terminal hydrolase regulation and dysfunction in
neurodegenerative disease pathogenesis
38 of 47
Regulation of Glutamate Transporter and Receptor Function by the
NHERF Scaffolding Proteins
39 of 47
Molecular Pathogenesis of Charcot-Marie-Tooth disease caused by
mutations in SIMPLE
40 of 47
Molecular Basis of NMDA Receptor Allosteric Regulation by New
Subunit-selective Modulators
41 of 47
Localization of Cav3.1 T-Type calcium channels in the thalamus of normal and parkinsonian monkeys: light and electron microscopic immunocytochemistry using subtype-specificantibodies
42 of 47
Loss of the Cortical Monoamine Projection Systems in the
MPTP-treated Nonhuman Primate Model of Parkinson's Disease
43 of 47
Microcircuitry of Group IIIMetabotropic Glutamate Receptors (mGluRs) in the Mouse Striatum
44 of 47
Structural Plasticity of GABAergic and Glutamatergic Terminals in the Ventral Motor and Caudal Intralaminar Thalamic Nuclei in MPTP-treated Parkinsonian Monkeys
45 of 47
Pharmacologically targeting the GABA-A receptors in neurological disease
46 of 47
Direct reprogramming of astrocytes to enhance recovery after stroke
47 of 47